Trial Profile
Effects of Atorvastatin on peripheral blood monocytes in patients with HIV associated neurological disorders.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Dementia; Neurological disorders
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- Acronyms HAND
- 08 Dec 2017 Status changed from active, no longer recruiting to completed.
- 13 Jan 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 13 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.